Related Experiment Video
Updated: Jun 10, 2025
10:58
Facilitating the Analysis of Immunological Data with Visual Analytic Techniques
Published on: January 2, 2011
10.1K
Immunological dynamics in MASH: from landscape analysis to therapeutic intervention
Lawan Rabiu1,2,3, Pengchao Zhang1,2, Lukman O Afolabi4
1Center for Protein and Cell-Based Drugs, Institute of Biomedicine and Biotechnology, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, 518055, People's Republic of China.
Journal of Gastroenterology
|October 14, 2024
Summary
Metabolic dysfunction-associated steatohepatitis (MASH) involves complex immune pathways. Targeting these immune cells offers promising therapeutic strategies for MASH, despite delivery challenges.
Area of Science:
- Hepatology
- Immunology
- Pharmacology
Background:
- Metabolic dysfunction-associated steatohepatitis (MASH), formerly NASH, is a progressive liver disease.
- Inflammation and fibrosis are key features of MASH, driven by immune and inflammatory pathways.
- Effective immune-targeted therapies for MASH are still under development.
Purpose of the Study:
- To review the critical role of immune cells in MASH pathogenesis.
- To highlight immune pathways as therapeutic targets for MASH.
- To discuss current and novel immunomodulatory treatment strategies for MASH.
Main Methods:
- Literature review of immune cell involvement in MASH.
- Analysis of therapeutic approaches targeting immune pathways in MASH.
- Discussion of challenges in MASH drug development and delivery.
Main Results:
- Immune cells are central to MASH etiology and pathophysiology.
- Modulating immune responses presents a viable therapeutic avenue for MASH.
- Significant challenges exist in liver-specific drug delivery and targeting diverse immune cells.
Conclusions:
- Understanding immune cell roles is crucial for MASH treatment.
- Targeting immune pathways holds promise for future MASH therapies.
- Overcoming drug delivery and targeting challenges is essential for clinical success.
